Home

Saba Capital Management, 10% Owner: abrdn Life Sciences Investors HQL Buy · Filed 24/04/22

Trade details

Type
Insider buy
Amount
$1,046,246.4
Shares · price
81,738 sh · $12.80 a share
Held after
2,694,511 sh
Trade date
24/04/18
Filed
24/04/22
Days to filing
4 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+3.1%

abrdn Life Sciences Investors trades, last 26 weeks

What else happened in abrdn Life Sciences Investors around then

Filed or reported within 30 days of the trade day · 24/03/19~24/05/18

Saba Capital Management's recent trades

  • Saba Capital Management

    BuyMexico Fund

    $25.2K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $118.4K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $21.1K

    Filed 10/01

  • Saba Capital Management

    BuyGabelli Healthcare & WellnessRx Trust

    $4,941

    Filed 10/01

  • Saba Capital Management

    SellPimco Dynamic Income Strategy Fund

    $180.9K

    Filed 10/01

Saba Capital Management, 10% Owner — bought $1M of abrdn Life Sciences Investors HQL · 81,738 sh @ $12.80 | Whalegun